Related Experiment Video
Updated: Jun 3, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
Hypertonic saline and mannitol therapy in critical care neurology
Holly E Hinson1, Deborah Stein, Kevin N Sheth
1Neurosciences Critical Care, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Abstract:
Osmotic agents play a vital role in the reduction of elevated intracranial pressure and treatment of cerebral edema in Neurologic critical care. Both mannitol and hypertonic saline reduce cerebral edema in many clinical syndromes, yet there is controversy over agent selection, timing, and dosing regimens. Despite the lack of randomized, controlled trials, our knowledge base on the appropriate clinical use of osmotic agents continues to expand. This review will summarize the evidence for the use of mannitol and hypertonic saline in a variety of disease states causing cerebral edema, as well as outlining monitoring and safety considerations.
Related Concept Videos
Cerebral Edema l: Introduction
Cytotoxic Edema: Pathophysiology
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Tonicity in Animals
Tonicity in Animals

